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Introduction
The standard in the treatment of rectal cancer is 
combined therapy that consists of rectal resection 
(anterior resection of the rectum, abdomino-perineal 
or abdomino-sacral amputation of the rectum or 
Hartmann’s procedure) together with the excision of 
regional lymph nodes, preoperative radiotherapy or 
chemoradiation and, in case of advanced tumours, 
adjuvant chemotherapy [1-3]. This approach is highly 
effective, but at the same time associated with a relatively 
high rate of complications, side-effects and, in the case of 
patients with a stoma, a significant decrease in the quality 
of life.
Increased sensitivity as to the patients’ quality of 
life, a trend towards minimizing surgical trauma and an 
increase in the number of elderly patients suffering from 
severe circulatory or respiratory disorders has brought 
on the development of less invasive or minimally inva-
sive surgical methods. Among these the most promising 
appears to be Transanal Endoscopic Microsurgery (TEM) 
introduced into clinical practice in 1983 by Gerhard 
Buess [4, 5]. This method allows to perform endolumi-
nal excision of rectal tumours together with the entire 
depth of the rectal wall. Excision is possible practically 
within the entire rectum and, at present, it is conside-
red standard treatment in case of rectal adenomas. It is 
also effectively applied in the treatment of inflammatory 
lesions, hyperplastic polyps and strictures [6-10]. The 
application of TEM in the treatment of rectal cancer still 
remains an open issue. It minimizes surgical trauma and 
the number of postoperative complications, decreases 
patient discomfort and reduces hospital stay. However, 
TEM does not allow to achieve free resection margins 
(proximal, distal and radial) as defined for standard radi-
cal resections and to excise the regional lymph nodes. 
For these reasons it is impossible to consider TEM as an 
equivalent to a resection procedure. It appears that TEM 
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may be applied in carefully selected group of patients 
with low risk rectal cancer (G1/G2, T1/T2, N0, M0) [3, 
7, 11-14].
The aim of our study was to analyze the results 
of TEM in the treatment of rectal cancer at the Ist 
Department of General and GI Surgery Jagiellonian 
University in Cracow.
Material and method
The analyzed group consisted of patients with low risk rectal 
cancer (Tis/T1/T2, N0, M0. G1/G2) treated with TEM between 
April 1996 and December 2003. The inclusion criteria were: 
tumour size of 3 cm or less, the distance from the anal verge 
between 2 and 12 cm for tumors localized on the anterior wall, 
and between 2 and 14 cm on the posterior and lateral walls.
Preoperative diagnostics included chest X-ray, colonoscopy 
of the entire colon, rectoscopy, abdominal ultrasound, histo-
pathologic examination of biopsy specimens obtained from 
the tumour and anorectal motility studies. In order to evaluate 
tumor infiltration depth and local lymph nodes metastases we 
used transrectal ultrasonography and, in selected cases, spiral 
CT of the pelvis.
Seven patients with T1/T2 tumours, 3 cm or less in dia-
meter, located on the posterior or lateral wall of the rectum 
underwent either neoadjuvant radiotherapy (25 Gy with 
a 4-5 week interval between radiotherapy and surgery) or 
chemoradiation (irradiation to a total dose of 50.4-55 Gy over 
5 weeks with 5-FU infusions in the first and the last week of 
radiotherapy; 5 weeks interval before operation).
Surgery was performed under general or epidural 
anaesthesia depending on general condition of the patients and 
concomitant diseases.
Tumour excision with the surrounding tissues was 
performed using operative rectoscope (Wolf), 40 mm in 
diameter and 10-20 cm long, under the control of stereoscopic 
optics. The instrument is equipped with 4 ports – 1 for optics 
and 3 for scissors, forceps, a multifunctional instrument, argon 
and ultrasound coagulation and a suction/lavage pump. The 
rectoscope was attached to the table with a stabilizing gantry and 
the rectum was insuflated with carbon dioxide. The procedures 
were recorded via the optics. In each case full thickness rectal 
wall (TEM-FT) excision was performed with 1 cm margin of 
macroscopically normal rectal wall. Additionally,5 mm margin 
of the rectal wall was excised. The rectum was reconstructed 
with a PDS 3/0 continuous stitches.
Final pathological examination of the paraffin-embedded 
specimens was performed by the same pathologist (K.N.). If 
healthy tissue margin was below 10 mm and/or the entire depth 
of the muscular layer was infiltrated the excision was considered 
oncologically non-radical.
Oral feeding was recommended 12-36 hrs after surgery 
while respiratory physiotherapy started 6-12 hrs after surgery 
with complete patient mobilization after 24 hrs. The patients 
were discharged home 48-72 hrs after surgery.
All the patients were followed-up prospectively every 
3 months in the first year, every 6 months until 5th postoperative 
year, and then every 18-month until 10 years after surgery. 
Follow-up regimen covers case history, physical examination, 
ultrasound, rectoscopy, TRUS colonoscopy, manometric 
examination, chest X-ray, and neoplasmatic markers (CEA 
and CA-19.9).
In all patients undergoing TEM procedures manometric 
examination is performed pre- and postoperatively and the 
patients undergoing neoadjuvant radiotherapy are subjected 
to sphincter manometry before irradiation and before surgery. 
During the follow-up period manometry is performed 3, 6 
and 12 months after surgery to evaluate resting anal pressure 
(RAP), squeeze anal pressure (SAP), high-pressure zone length 
(HPZL) and radial asymmetry (RA) [15].
Endorectal ultrasonography was the basic method used 
to evaluate tumour size, regional lymph nodes, sphincters, 
and scars after surgery. Due to the high sensitivity and 
specificity of TRUS, comparable with MRI, wider availability 
of the examination and lower cost, spiral CT of the pelvis was 
performed only in doubtful cases or suspicion of recurrence 
[16-19].
Results
Between April 1996 and December 2003, 141 TEM 
procedures were performed. The indications included: 
adenoma in 69 cases, carcinoma in 52, carcinoid in 4, and 
GIST in 2 cases (Figure 1).
Fifty-two patients with rectal carcinoma were ope-
rated. Of these, 2 patients with advanced cancer and 
1 patient with T3 tumour were excluded from further 
analysis.
Treatment results were analyzed for 49 patients with 
rectal cancer. A group consisted of 22 women (44.9%) 
and 27 men (55.1%), aged between 33 and 85 years 
(mean age: 61.3 years). Tumor diameter (Tis and T1/T2 
combined) was between 1 and 8 cm (mean: 3.2 cm), 
the distance from the transitional zone was between 1 
and 18 cm (mean: 7.6 cm) (Table I). Postoperative pat-
Figure 1. Indications for TEM procedure
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hologic examination revealed carcinoma in situ in 28 
cases (57.1%) and invasive cancer (T1/T2) in 21 cases 
(42.9%). Seven patients (33.3%) with T1/T2 tumours 
received neoadjuvant therapy: 5-day radiotherapy in 3 
cases (14.3%) and chemotherapy in 4 cases (19%). The 
results are shown in Tables II and III.
In 7 (14.3%) of 49 patients the operation was onco-
logically nonradical (healthy tissue margin of less than 
10 mm and infiltration of the entire width of the rectal 
wall). Six of these underwent radical surgery and one 
refused consent to reoperation. Complications occurred 
in 9 (18.75%) patients treated with TEM and included 
dehiscence of the suture line in 1, transient anorectal 
dysfunction in 3, meningeal reaction after epidural anaes-
thesia in 1, pneumonia in 1, and intraoperative peritoneal 
injury in 1 case. None of the patients demanded reope-
ration due to the complications and there was no case 
of death in the immediate postoperative period. Local 
recurrence was observed in 1 case (2.3%), and 2 (4.6%) 
patients developed distal metastases. Two patients died 
due to disease progression.
C a r c i n o m a  i n  s i t u
In the entire group of 49 patients carcinoma in situ was 
diagnosed in 28 cases. Three patients (10.7%) were 
reoperated due to the lack of oncological radicality 
in the primary excised specimen; 1 patient underwent 
abdomino-perineal resetion of the rectum, another 1 
anterior resection of the rectum, and 1 was reoperated 
with TEM. Local recurrence was observed in 1/25 cases 
(4%). Five (17.8%) patients developed the following 
complications: anorectal dysfunction in 2 cases, meningel 
reaction after a epidural anaesthesia in 1, peritoneal 
injury in 1, and pneumonia in 1 case. There were no 
cancer-related deaths in this subgroup.
I n v a s i v e  c a r c i n o m a  ( T 1 / T 2 )
In the entire group of 49 patients T1 and/or T2 
carcinoma was diagnosed in 21 cases, 7 of whom (33.3%) 
underwent neoadjuvant radio- or radiochemotherapy. 
In 14 cases (66.7%) the treatment was limited to local 
excision without neoadjuvant therapy. Three patients 
underwent abdomino-perineal rectum resection due 
to the lack of oncological radicality. One of them 
was operated immediately after TEM procedure 
based on the intraoperative pathologic findings, and 
another one refused consent to abdomino-perineal 
resection. Complications were observed in 4/20 
cases: 1 case of dehiscence of suture line,1 case of 
peritoneal injury in the course of the procedure, 1 case 
of stool incontinency, and 1 case of pneumonia in the 
postoperative period. Two patients (11.8%) underwent 
surgery for recurrence.
In the subgroup of patients receiving radiotherapy 
complete response was obtained in 3 cases – there were 
no cancer cells in the analyzed specimen; in 2 cases we 
observed downstaging while in another 2 cases radiothe-
rapy had no effect on the stage of the tumour (Table IV). 
One patient (14.3%) was reoperated due to the lack of 
oncological radicality. One patient (14.3%) developed 
distal metastases and this patient eventually died due to 
cancer progression.
Table I. Characteristics of the patient group
Gender
male 23
female 30
Average age (years) 61.3 ± 12
Staging
Tis 28
T1/T2 21
Tumour size (cm)
average 3.2 ± 1.7
min 1
max 8
Distance from transitional zone (cm)
average 7.6 ± 3.9
min 1
max 18
Table II. Results of transanal endoscopic microsurgery
Tis T1/T2 Łącznie
Operated patients 28 21 49
Incomplete excision 3
(10.7%)
4
(19%)
7
(14.3%)
Local recurrence 1
(4%)
– 1
(2.4%)
Distal metastases – 2
(11.8%)
2
(4.8%)
Complications 5
(17.8%)
4
(20%)
9
(18.7%)
Mortality – 2
(9.5%)
2
(4.1%)
Table III. Complications after TEM
Complications Tis T1/T2 Overall
Intraperitoneal perforation 1 1 2
Dehiscence of the suture line – 1 1
Pneumonia 1 1 2
Meningeal reaction after anaesthesia 1 – 1
Anorectal dysfunction 2 1 3
Overall 5 4 9
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In the subgroup of patients without neoadjuvant 
therapy, 2 patients (14.3%) were reoperated due to the 
lack of oncological radicality, while 1 patient refused 
consent to reoperation. During the follow-up 1 patient 
(8.3%) developed distal metastases and died eventually 
due to disease progression.
Discussion
Radical operation (anterior resection of the rectum and 
abdomino-sacral or abdomino-perineal amputation of 
the rectum) is the standard in the treatment of rectal 
tumours. Although the need for radical treatment of 
advanced rectal tumours has not been questioned, yet in 
the case of adenomas and non-advanced tumours there 
is a demand for a therapeutic methods that bring about 
comparable low recurrence rates and long-term survivals 
with distinctly lower number of complications.
TEM procedures have a relatively low recurrence 
rate (thus comparing favourably with conventional local 
excision using Parks dilators) and a significantly lower 
complication rate when compared to conventional resec-
tions. This is associated with the used equipment and 
surgical technique [7]. In 3 cases of low tumour localiza-
tion adjacent to the transitional zone, TEM excision was 
extended by the resection of the lower part of the tumour 
using Parks dilators.
In the entire patient group complications were 
observed in 18.75% of cases (17.8% of patients with 
carcinoma in situ and 20% of patients with infiltrating 
cancer – NS). The number of complications is similar to 
the reported in literature, where it ranges between 3.4% 
[2] and 38.2% [20] with neither quantitative nor qualita-
tive differences [2, 14, 20-22]. Transient anorectal dys-
function was the most common complication, observed 
in 3 cases. In another 2 cases we observed pneumonia, 
1 patient developed wound dehiscence, and in 1 case the 
peritoneum was injured intraoperatively. None of our 
patients required reoperation due to the complications 
as opposed to the observations of other authors [7, 22]. 
There are reports from the literature describing single 
death cases as a result of TEM procedures mostly due 
to cardio-pulmonary insufficiency [22] or surgical wound 
sepsis [23]. There were no death cases in the analyzed 
group of patients due to the postoperative complications 
[7, 22, 23].
The benefit of radical surgery, especially in the case 
of advanced rectal tumours, is the possibility to perform 
lymphadenectomy and achieving oncological radicality 
due to the precise rectal cancer staging in the entire spe-
cimen, including the entire rectal wall and mesorectum. 
This is reflected in a relatively low rate of recurrences 
and an increased 5-year survival. With TEM excision it 
is not possible to perform lymphadenectomy, however, 
as reported in the literature, regional lymph node meta-
stases were found in 0 – 12% of T1 tumors and in 12 
– 28% of T2 tumors (24-26). This may account for the 
poor results of the TEM in more advanced tumours [11, 
14]. In selected group of patients, who meet the criteria 
Figure 2. The instrumentation for transanal endoscopic microsurgery
Table IV. Results of treatment of rectal cancer
with and without radiotherapy – a comaprison
Radiotherapy Without radiotherapy
Number of patients 7 14
Incomplete excision 1(14.3%)
3
(21.4%)
Recurrence 1(16.6%)
1
(9.1%)
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of Hermanek and Gall introduced in 1986, the results 
of local excision are comparable with those achieved by 
radical surgery [2, 14, 24]. In the follow-up local recur-
rence and/or distal metastases were found in 3/42 cases 
(7.1%). In the Tis subgroup there was 1 case of local 
recurrence (4%). In the T1/T2 subgroup there were 2 
(11.8%) recurrences (liver metastases) and 2 patients 
died due to disease progression. The results obtained in 
our patients are similar to reported by other authors [2, 
11, 14] and indicate the necessity of careful patients qua-
lification to TEM procedures. Two cases of distal meta-
stases (11.8%) make the use of TEM in patients with 
T2 or more advanced rectal cancer questionable. The 
neoadjuvant radiotherapy was applied with the intent 
of sterilising the structures of the mesorectum. Due to 
small number of patients who underwent preoperative 
radiotherapy the effect of this treatment is not clear. 
However, some benefits – such as downstaging or even 
a total response, i.e. disappearance of cancer cells were 
observed. Though some authors reported significantly 
improved long-term results after neoadjuvant radiothera-
py [3, 21], comparable with the results of radical surgery, 
in the prevalent number of studies the results are com-
parable with ours [3, 21, 22, 27, 28]. The results obtained 
in our study are promising and should be analyzed in 
further clinical trials.
Conclusions
TEM excisions are useful for the treatment of non-
advanced rectal tumours less than 3 cm in diameter.
Due to the necessity of providing oncological radi-
cality and to the technical limitations of the technique, 
TEM calls for very careful patient selection.
The use of TEM in the more advanced tumours 
remains an open issue.
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